Autoinjector Assembly for the Entire Lifecycle
Master the complexity of autoinjector assembly with a modular automation platform that delivers process control, safety, and scalability from development to commercial production.
Autoinjector Assembly for the Entire Lifecycle
Master the complexity of autoinjector assembly with a modular automation platform that delivers process control, safety, and scalability from development to commercial production.
Autoinjector Assembly for the Entire Lifecycle
Master the complexity of autoinjector assembly with a modular automation platform that delivers process control, safety, and scalability from development to commercial production.
Is Your Automation Ready for the Responsibility of Autoinjectors?
Autoinjectors are an integral part of the therapy itself, directly impacting patient safety and dosing accuracy. As device designs evolve, regulations tighten, and production scales, rigid, product-specific assembly lines increase risk and create validation bottlenecks. This challenging reality requires automation designed to manage risk throughout the device lifecycle.
Is Your Automation Ready for the Responsibility of Autoinjectors?
Autoinjectors are an integral part of the therapy itself, directly impacting patient safety and dosing accuracy. As device designs evolve, regulations tighten, and production scales, rigid, product-specific assembly lines increase risk and create validation bottlenecks. This challenging reality requires automation designed to manage risk throughout the device lifecycle.
Is Your Automation Ready for the Responsibility of Autoinjectors?
Autoinjectors are an integral part of the therapy itself, directly impacting patient safety and dosing accuracy. As device designs evolve, regulations tighten, and production scales, rigid, product-specific assembly lines increase risk and create validation bottlenecks. This challenging reality requires automation designed to manage risk throughout the device lifecycle.
One Platform. Total Control.
The ESSERT MicroFactory Assembly Line separates critical process steps into independent modules. This gives you the precision of a custom machine with the flexibility of a robot - perfect for high-value combination products.
Lifecycle Modularity
The platform is designed to support your autoinjector program from early-stage development and design iterations through to full commercial scale-up.
Controlled Flexibility
Make controlled design changes by adapting individual modules, localizing the impact and simplifying change management in a regulated environment.
Predictable Scale-Up
Add capacity or new process steps like enhanced inspection by integrating new modules with standardized interfaces, ensuring a predictable scale-up path.
Pre-Commissioning
Each module is fully commissioned and tested before delivery, reducing on-site complexity and enabling a faster, more predictable ramp-up.
Robotic Repeatability
Critical assembly operations are executed by robots with the highest precision and repeatability, ensuring consistent quality for patient-critical devices.
Localized Changes
Because existing qualified modules remain unchanged when new ones are added, process changes stay localized, controlled, and manageable.
One Platform. Total Control.
The ESSERT MicroFactory Assembly Line separates critical process steps into independent modules. This gives you the precision of a custom machine with the flexibility of a robot - perfect for high-value combination products.
Lifecycle Modularity
The platform is designed to support your autoinjector program from early-stage development and design iterations through to full commercial scale-up.
Controlled Flexibility
Make controlled design changes by adapting individual modules, localizing the impact and simplifying change management in a regulated environment.
Predictable Scale-Up
Add capacity or new process steps like enhanced inspection by integrating new modules with standardized interfaces, ensuring a predictable scale-up path.
Pre-Commissioning
Each module is fully commissioned and tested before delivery, reducing on-site complexity and enabling a faster, more predictable ramp-up.
Robotic Repeatability
Critical assembly operations are executed by robots with the highest precision and repeatability, ensuring consistent quality for patient-critical devices.
Localized Changes
Because existing qualified modules remain unchanged when new ones are added, process changes stay localized, controlled, and manageable.
One Platform. Total Control.
The ESSERT MicroFactory Assembly Line separates critical process steps into independent modules. This gives you the precision of a custom machine with the flexibility of a robot - perfect for high-value combination products.
Lifecycle Modularity
The platform is designed to support your autoinjector program from early-stage development and design iterations through to full commercial scale-up.
Controlled Flexibility
Make controlled design changes by adapting individual modules, localizing the impact and simplifying change management in a regulated environment.
Predictable Scale-Up
Add capacity or new process steps like enhanced inspection by integrating new modules with standardized interfaces, ensuring a predictable scale-up path.
Pre-Commissioning
Each module is fully commissioned and tested before delivery, reducing on-site complexity and enabling a faster, more predictable ramp-up.
Robotic Repeatability
Critical assembly operations are executed by robots with the highest precision and repeatability, ensuring consistent quality for patient-critical devices.
Localized Changes
Because existing qualified modules remain unchanged when new ones are added, process changes stay localized, controlled, and manageable.
Precision Where Patient Safety Depends on It
For combination products, technical performance is medical performance. Our software-driven architecture ensures that every parameter - from joining force to visual inspection - is monitored, recorded, and compliant with GMP standards.
Precision Where Patient Safety Depends on It
For combination products, technical performance is medical performance. Our software-driven architecture ensures that every parameter - from joining force to visual inspection - is monitored, recorded, and compliant with GMP standards.
Precision Where Patient Safety Depends on It
For combination products, technical performance is medical performance. Our software-driven architecture ensures that every parameter - from joining force to visual inspection - is monitored, recorded, and compliant with GMP standards.
Big Players like ROCHE rely on our MicroFactory Assembly Line
"At Roche, we were looking for a modular, flexible solution for assembling different devices and found this solution in ESSERTs automation ecosystem. The collaboration with ESSERT was characterized by a high level of innovation.”
Philip Schneider
Drug Product Manufacturing Network Technology Lead
Big Players like ROCHE rely on our MicroFactory Assembly Line
"At Roche, we were looking for a modular, flexible solution for assembling different devices and found this solution in ESSERTs automation ecosystem. The collaboration with ESSERT was characterized by a high level of innovation.”
Philip Schneider
Department manager for plant
and site development.
Big Players like ROCHE rely on our MicroFactory Assembly Line
"At Roche, we were looking for a modular, flexible solution for assembling different devices and found this solution in ESSERTs automation ecosystem. The collaboration with ESSERT was characterized by a high level of innovation.”
Philip Schneider
Drug Product Manufacturing Network Technology Lead
Configure by Criticality, Not Convenience
Start with the core functions: Device feeding, primary assembly, and final labeling.
Scale up without revalidating the whole line. Add modules for functional testing, vision inspection of safety clips, serialization, and more.
Configure by Criticality, Not Convenience
Start with the core functions: Device feeding, primary assembly, and final labeling.
Scale up without revalidating the whole line. Add modules for functional testing, vision inspection of safety clips, serialization, and more.
Configure by Criticality, Not Convenience
Start with the core functions: Device feeding, primary assembly, and final labeling.
Scale up without revalidating the whole line. Add modules for functional testing, vision inspection of safety clips, serialization, and more.
Pre-series Validation
Use our standardized process modules to automate your manual processes. You can validate the automated processes in the pre-series and later transfer them to a MicroFactory Line with little effort, thus scaling your production.
Pre-series Validation
Use our standardized process modules to automate your manual processes. You can validate the automated processes in the pre-series and later transfer them to a MicroFactory Line with little effort, thus scaling your production.
Pre-series Validation
Use our standardized process modules to automate your manual processes. You can validate the automated processes in the pre-series and later transfer them to a MicroFactory Line with little effort, thus scaling your production.
FAQs
Frequently Asked Questions
Most common Questions about the Autoinjector Assembly Line.
What throughput can ESSERT's autoinjector assembly platform achieve?
ESSERT's autoinjector assembly is designed for High-Mix/Low-Volume (HMLV) production and scales with your pipeline. Because the platform is modular, throughput is a function of how many modules are deployed — typical configurations run from clinical-scale (pilot/lab) to commercial-scale production. The architecture is pre-commissioned and validated before delivery, which means you can add or remove modules without re-qualifying the entire line. Exact numbers depend on device complexity (2-part vs. multi-part assembly, safety device integration, labeling requirements) and are confirmed in the feasibility phase.
How long does a format changeover take on ESSERT's autoinjector line?
Format changeovers on the MicroFactory-based Autoinjector Assembly platform take minutes, not hours. This is achieved through software-driven recipe management — no mechanical format parts are required. Camera-based line clearance verifies the changeover automatically, and the PLC-per-module architecture means only affected modules reconfigure. Compared to traditional rigid assembly lines, where changeovers often take hours or a full shift, this is an order-of-magnitude improvement — especially valuable for HMLV production and combination products.
Is the ESSERT autoinjector assembly line GMP-compliant?
Yes. The platform is designed for GMP-compliant pharmaceutical manufacturing from the ground up. Every critical parameter — joining force, visual inspection, torque values — is monitored and recorded for audit trails. The software architecture provides full traceability per device. Modules are pre-qualified before shipment (FAT/SAT), and the system is compatible with cleanroom environments up to ISO Class 5. This applies to both FDA and EU GMP regulatory frameworks.
How do you scale from clinical production to commercial volumes?
Scaling is done by adding modules, not replacing the line. The lifecycle modularity principle means the same platform serves early-stage development, clinical trials, and commercial production. Each added module has standardized interfaces (Plug & Produce), so existing qualified modules stay unchanged — only the new additions require validation. This protects your initial CapEx investment and dramatically reduces validation effort compared to traditional scale-up, where a new line typically requires full re-qualification.
Which device types does ESSERT's autoinjector assembly platform support?
The platform is built around processes, not specific devices. Core functions include device feeding, primary assembly (joining, functional testing), and final labeling. It supports common autoinjector formats including pen-style injectors, single-use autoinjectors, and combination products with integrated safety devices. Expandable modules cover functional testing, vision inspection, and serialization. This process-first architecture means the same platform can assemble multiple device variants on a single line with recipe-based switching.
FAQs
Frequently Asked Questions
Most common Questions about the Autoinjector Assembly Line.
What throughput can ESSERT's autoinjector assembly platform achieve?
ESSERT's autoinjector assembly is designed for High-Mix/Low-Volume (HMLV) production and scales with your pipeline. Because the platform is modular, throughput is a function of how many modules are deployed — typical configurations run from clinical-scale (pilot/lab) to commercial-scale production. The architecture is pre-commissioned and validated before delivery, which means you can add or remove modules without re-qualifying the entire line. Exact numbers depend on device complexity (2-part vs. multi-part assembly, safety device integration, labeling requirements) and are confirmed in the feasibility phase.
How long does a format changeover take on ESSERT's autoinjector line?
Format changeovers on the MicroFactory-based Autoinjector Assembly platform take minutes, not hours. This is achieved through software-driven recipe management — no mechanical format parts are required. Camera-based line clearance verifies the changeover automatically, and the PLC-per-module architecture means only affected modules reconfigure. Compared to traditional rigid assembly lines, where changeovers often take hours or a full shift, this is an order-of-magnitude improvement — especially valuable for HMLV production and combination products.
Is the ESSERT autoinjector assembly line GMP-compliant?
Yes. The platform is designed for GMP-compliant pharmaceutical manufacturing from the ground up. Every critical parameter — joining force, visual inspection, torque values — is monitored and recorded for audit trails. The software architecture provides full traceability per device. Modules are pre-qualified before shipment (FAT/SAT), and the system is compatible with cleanroom environments up to ISO Class 5. This applies to both FDA and EU GMP regulatory frameworks.
How do you scale from clinical production to commercial volumes?
Scaling is done by adding modules, not replacing the line. The lifecycle modularity principle means the same platform serves early-stage development, clinical trials, and commercial production. Each added module has standardized interfaces (Plug & Produce), so existing qualified modules stay unchanged — only the new additions require validation. This protects your initial CapEx investment and dramatically reduces validation effort compared to traditional scale-up, where a new line typically requires full re-qualification.
Which device types does ESSERT's autoinjector assembly platform support?
The platform is built around processes, not specific devices. Core functions include device feeding, primary assembly (joining, functional testing), and final labeling. It supports common autoinjector formats including pen-style injectors, single-use autoinjectors, and combination products with integrated safety devices. Expandable modules cover functional testing, vision inspection, and serialization. This process-first architecture means the same platform can assemble multiple device variants on a single line with recipe-based switching.
FAQs
Frequently Asked Questions
Most common Questions about the Autoinjector Assembly Line.
What throughput can ESSERT's autoinjector assembly platform achieve?
ESSERT's autoinjector assembly is designed for High-Mix/Low-Volume (HMLV) production and scales with your pipeline. Because the platform is modular, throughput is a function of how many modules are deployed — typical configurations run from clinical-scale (pilot/lab) to commercial-scale production. The architecture is pre-commissioned and validated before delivery, which means you can add or remove modules without re-qualifying the entire line. Exact numbers depend on device complexity (2-part vs. multi-part assembly, safety device integration, labeling requirements) and are confirmed in the feasibility phase.
How long does a format changeover take on ESSERT's autoinjector line?
Format changeovers on the MicroFactory-based Autoinjector Assembly platform take minutes, not hours. This is achieved through software-driven recipe management — no mechanical format parts are required. Camera-based line clearance verifies the changeover automatically, and the PLC-per-module architecture means only affected modules reconfigure. Compared to traditional rigid assembly lines, where changeovers often take hours or a full shift, this is an order-of-magnitude improvement — especially valuable for HMLV production and combination products.
Is the ESSERT autoinjector assembly line GMP-compliant?
Yes. The platform is designed for GMP-compliant pharmaceutical manufacturing from the ground up. Every critical parameter — joining force, visual inspection, torque values — is monitored and recorded for audit trails. The software architecture provides full traceability per device. Modules are pre-qualified before shipment (FAT/SAT), and the system is compatible with cleanroom environments up to ISO Class 5. This applies to both FDA and EU GMP regulatory frameworks.
How do you scale from clinical production to commercial volumes?
Scaling is done by adding modules, not replacing the line. The lifecycle modularity principle means the same platform serves early-stage development, clinical trials, and commercial production. Each added module has standardized interfaces (Plug & Produce), so existing qualified modules stay unchanged — only the new additions require validation. This protects your initial CapEx investment and dramatically reduces validation effort compared to traditional scale-up, where a new line typically requires full re-qualification.
Which device types does ESSERT's autoinjector assembly platform support?
The platform is built around processes, not specific devices. Core functions include device feeding, primary assembly (joining, functional testing), and final labeling. It supports common autoinjector formats including pen-style injectors, single-use autoinjectors, and combination products with integrated safety devices. Expandable modules cover functional testing, vision inspection, and serialization. This process-first architecture means the same platform can assemble multiple device variants on a single line with recipe-based switching.
Let’s Talk
Automation is a long-term commitment. We partner with manufacturers who think in lifecycles. If you are evaluating automation for a new product, scaling a process, or preparing for a future pipeline - let’s talk.
Let’s Talk
Automation is a long-term commitment. We partner with manufacturers who think in lifecycles. If you are evaluating automation for a new product, scaling a process, or preparing for a future pipeline - let’s talk.
Let’s Talk
Automation is a long-term commitment. We partner with manufacturers who think in lifecycles. If you are evaluating automation for a new product, scaling a process, or preparing for a future pipeline - let’s talk.
See what's new
ESSERT Robotics Expands to North America
ESSERT Robotics opens its North American headquarters in Raleigh, NC - 10,000 sq. ft. of office and production space, going live April 1st, 2026.
ESSERT Robotics at INTERPHEX 2026
ESSERT Robotics is exhibiting at INTERPHEX 2026 in New York City - visit us at Booth 1016 and see the award-winning RoboTub live on the show floor.
Automating the Full Blister Line: From Product Loading to Inspection
Ask most Pharma or MedTech production managers where their biggest packaging bottleneck is, and they will point somewhere on the blister line. It might be the manual product loading step, ...
See what's new
ESSERT Robotics Expands to North America
ESSERT Robotics opens its North American headquarters in Raleigh, NC - 10,000 sq. ft. of office and production space, going live April 1st, 2026.
ESSERT Robotics at INTERPHEX 2026
ESSERT Robotics is exhibiting at INTERPHEX 2026 in New York City - visit us at Booth 1016 and see the award-winning RoboTub live on the show floor.
Automating the Full Blister Line: From Product Loading to Inspection
Ask most Pharma or MedTech production managers where their biggest packaging bottleneck is, and they will point somewhere on the blister line. It might be the manual product loading step, ...
See what's new
ESSERT Robotics Expands to North America
ESSERT Robotics opens its North American headquarters in Raleigh, NC - 10,000 sq. ft. of office and production space, going live April 1st, 2026.
ESSERT Robotics at INTERPHEX 2026
ESSERT Robotics is exhibiting at INTERPHEX 2026 in New York City - visit us at Booth 1016 and see the award-winning RoboTub live on the show floor.
Automating the Full Blister Line: From Product Loading to Inspection
Ask most Pharma or MedTech production managers where their biggest packaging bottleneck is, and they will point somewhere on the blister line. It might be the manual product loading step, ...
Contact our team
From initial questions to your custom MicroFactory solutions – our team is here to assist you.
Contact our team
From initial questions to your custom MicroFactory solutions – our team is here to assist you.
Contact our team
From initial questions to your custom MicroFactory solutions – our team is here to assist you.
